Hatano Hiroshi, Morita Tetsuro, Ariizumi Takashi, Kawashima Hiroyuki, Ogose Akira
Department of Orthopedic Surgery, Niigata Cancer Center Hospital, Niigata 951-8566, Japan.
Division of Orthopedic Surgery, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Oncol Lett. 2014 Jul;8(1):384-386. doi: 10.3892/ol.2014.2082. Epub 2014 Apr 22.
Secondary osteosarcoma from fibrous dysplasia (FD) is very rare. The etiology of FD is linked to activating missense mutations of the guanine nucleotide-binding protein α-subunit () gene, which encodes the stimulatory α subunit of the G protein (Gα) and is located at chromosome 20q13. These mutations are central to the pathogenesis of FD; however, it is not known whether Gα mutations are retained following malignant transformation in FD. In addition, to the best of our knowledge, no studies have been performed on chromosomal analysis of secondary osteosarcoma from FD. The present study presents a case of secondary osteosarcoma arising from polyostotic FD in a 72-year-old male. Chromosomal analysis showed 44, X, -Y, add(4)(p11), add(5)(p15), der(11)add(11)(p15)t(1;11)(q21;q23), add(12)(q11), -13, der(22)t(12;22)(q11;p12). Reverse transcription-polymerase chain reaction (RT-PCR) analysis demonstrated the presence of a Gα mutation in both the primary tumor cells and secondary osteosarcoma cells. There was no alteration in this mutation in the region of malignant transformation, which suggests that this mutation may be a useful clinical marker for distinguishing osteosarcoma (primary osteosarcoma) from secondary osteosarcoma arising from FD.
骨纤维发育不良(FD)继发骨肉瘤非常罕见。FD的病因与鸟嘌呤核苷酸结合蛋白α亚基()基因的激活错义突变有关,该基因编码G蛋白(Gα)的刺激性α亚基,位于20号染色体q13区。这些突变是FD发病机制的核心;然而,尚不清楚FD发生恶性转化后Gα突变是否仍然存在。此外,据我们所知,尚未对FD继发骨肉瘤进行染色体分析的研究。本研究报告了1例72岁男性多骨型FD继发骨肉瘤的病例。染色体分析显示44,X,-Y,add(4)(p11),add(5)(p15),der(11)add(11)(p15)t(1;11)(q21;q23),add(12)(q11),-13,der(22)t(12;22)(q11;p12)。逆转录-聚合酶链反应(RT-PCR)分析表明,原发肿瘤细胞和继发骨肉瘤细胞中均存在Gα突变。在恶性转化区域该突变没有改变,这表明该突变可能是区分骨肉瘤(原发性骨肉瘤)与FD继发骨肉瘤的有用临床标志物。